Press release
Retinal Edema Market Expected to Witness Significant Growth Through 2032, Driven by Recent FDA Approvals and a Robust Clinical Pipeline | DelveInsight
The retinal edema market is witnessing significant growth, primarily fueled by the increasing prevalence of conditions associated with retinal edema, particularly diabetic macular edema, and a robust pipeline of innovative therapies by pharmaceutical giants, including Regeneron, Genentech/Roche, Opthea, Novartis, and Kodiak Sciences, among others.DelveInsight's "Retinal Edema - Market Insight, Epidemiology And Market Forecast - 2032 [https://www.delveinsight.com/report-store/retinal-edema-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]" report delivers an in-depth understanding of the retinal edema treatment market, historical and forecasted epidemiology, and market trends across the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan. The report further assesses current treatment practices, emerging drugs, and retinal edema market drivers, providing a comprehensive overview of the factors influencing this rapidly evolving therapeutic landscape.
The retinal edema treatment market is experiencing strong growth across the 7MM, driven by rising cases of diabetic retinopathy, age-related macular degeneration, and retinal vein occlusion. Furthermore, the US holds the largest retinal edema market share, mainly due to a large patient pool, high adoption of advanced therapies, and ongoing research and development activities, which collectively drive greater demand and higher spending on treatment.
Download the Retinal Edema Market Forecast Report to understand which factors are driving the Retinal Edema market @ Retinal Edema Market Trends [https://www.delveinsight.com/sample-request/retinal-edema-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr].
Retinal edema epidemiological studies indicate an increasing prevalence in all the major markets, mainly due to rising rates of diabetes, aging populations, and associated conditions like diabetic retinopathy, age-related macular degeneration, and retinal vein occlusion. Additionally, diabetic macular edema represents one of the most prevalent forms of retinal edema. According to DelveInsight's research, more than 5% of people with diabetes globally have diabetic macular edema, with prevalence rates varying across regions. Among patients with type 1 diabetes, diabetic macular edema prevalence ranges between 4.2% and 8%, while in patients with type 2 diabetes, prevalence ranges from 1.5% to 13%.
Discover evolving trends in the Retinal Edema patient pool forecasts @ Retinal Edema Epidemiological Analysis [https://www.delveinsight.com/sample-request/retinal-edema-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr].
The current retinal edema treatment landscape is dominated by anti-VEGF therapies, which effectively reduce fluid buildup and improve vision. Key drugs include EYLEA HD (aflibercept) from Regeneron Pharmaceuticals (NASDAQ: REGN) and Bayer (ETR: BAYN), offering extended dosing intervals. VABYSMO (faricimab-svoa), developed by Genentech, represents a groundbreaking advancement as the first and only FDA-approved injectable eye medicine for both wet AMD and DME. Biosimilars like BYOOVIZ (Samsung Bioepis) and YESAFILI (Biocon Biologics) provide more cost-effective options with similar efficacy. Other notable companies in the field are Novartis, Genentech, and AbbVie, all contributing to ongoing innovation, including long-acting drug delivery systems and emerging oral therapies.
According to DelveInsight's pipeline analysis of retinal edema treatments, several biopharmaceutical companies, including Roche, Genentech, Kodiak Sciences, Outlook Therapeutics, Taiwan Liposome Company, and Ocuphire, are making significant progress in developing advanced therapies that could transform care for this condition.
Kodiak Sciences is advancing tarcocimab tedromer (KSI-301), which is engineered for extended durability in treating retinal vein occlusion and diabetic macular edema (DME). They are also working on KSI-101, which targets macular edema caused by inflammation and DME. Both treatments are currently in late-stage clinical trials.
Outlook Therapeutics is progressing with LYTENAVA (ONS-5010), a novel ophthalmic formulation of bevacizumab specifically designed for retinal diseases. Meanwhile, the Taiwan Liposome Company is developing TLC399 (ProDex), a long-acting injectable form of dexamethasone that uses a proprietary sustained-release delivery platform to treat macular edema.
In addition, oral therapies are emerging in this field, including APX3330 by Ocuphire, a Ref-1 inhibitor currently in development for diabetic retinopathy.
The report also offers a thorough analysis of recent developments in the retinal edema therapeutic landscape and discusses their implications for the competitive environment surrounding this condition.
In early 2025, several important FDA approvals and clinical trial updates have influenced the retinal edema treatment landscape. In February 2025, the FDA approved Roche's Susvimo (ranibizumab injection) for diabetic macular edema. This marked the introduction of the first continuous delivery treatment for diabetic macular edema, significantly reducing the need for frequent eye injections. Additionally, in March 2025, the FDA approved ENCELTO (revakinagene taroretcel-lwey), developed by Neurotech Pharmaceuticals, as the first treatment for Macular Telangiectasia type 2, utilizing an innovative encapsulated cell therapy platform.
New clinical trials are also in progress, including studies of a higher-dose aflibercept by Bayer for treating macular edema secondary to retinal vein occlusion, and Unity Biotechnology's Phase III trial of foselutoclax for diabetic macular edema.
Discover evolving trends in the Retinal Edema treatment landscape @ Retinal Edema Recent Developments [https://www.delveinsight.com/sample-request/retinal-edema-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr].
Despite these advancements, there are several retinal edema market challenges. In April 2025, the FDA delivered a complete response letter for longer dosage intervals (24 weeks) in aflibercept for DME and wet AMD, indicating regulatory hurdles for extended treatment protocols. Additionally, inconsistencies in diagnostic approaches and limited access to specialized eye care remain barriers to optimal patient management across different regions.
Looking ahead, the retinal edema market is poised for continued growth driven by several factors, including the integration of AI in imaging diagnostics and personalized treatment approaches based on molecular profiling. As research continues to uncover the complex pathophysiology of retinal edema and associated conditions, the market is expected to expand substantially, offering more tailored treatment options and improved outcomes for patients suffering from this vision-threatening condition.
Table of Contents
1. Key Insights
2. Executive Summary of Retinal Edema
3. Retinal Edema Competitive Intelligence
4. Retinal Edema: Market Overview at a Glance
5. Retinal Edema: Disease Background and Overview
6. Patient Journey
7. Retinal Edema Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Retinal Edema Unmet Needs
10. Key Endpoints of Retinal Edema Treatment
11. Retinal Edema Marketed Products
12. Retinal Edema Emerging Therapies
13. Retinal Edema: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Retinal Edema
17. KOL Views
18. Retinal Edema Market Drivers
19. Retinal Edema Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Related Reports
Retinal Edema Pipeline Insight [https://www.delveinsight.com/sample-request/retinal-edema-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]
Retinal Edema Pipeline Insight provides comprehensive insights about the Retinal Edema pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the Retinal Edema companies, including Roche, Novartis, Bayer, Regeneron, AbbVie, Sanofi, Genentech, and Iveric Bio, among others.
About DelveInsight
DelveInsight is a leading market research and consulting firm specializing in disease-specific insights and therapeutic market analysis. Their reports integrate real-world data, clinical trial findings, and expert interviews to deliver comprehensive industry intelligence.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Arpit Anand
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=retinal-edema-market-expected-to-witness-significant-growth-through-2032-driven-by-recent-fda-approvals-and-a-robust-clinical-pipeline-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
                     Copy
                  
                 Please set a link in the press area of your homepage to this press release on openPR.  openPR disclaims liability for any content contained in this release. 
    You can edit or delete your press release Retinal Edema Market Expected to Witness Significant Growth Through 2032, Driven by Recent FDA Approvals and a Robust Clinical Pipeline | DelveInsight here
News-ID: 4008185 • Views: …
More Releases from ABNewswire
 
                                            
                                                    Welding Equipment, Accessories, and Consumables Market 2025 : Business Growth Po …                                                
                                            
                                        
                                            The Welding Equipment, Accessories, and Consumables Market is witnessing steady growth, driven by rising demand from construction, automotive, and manufacturing sectors. Key players such as Lincoln Electric, ESAB, Fronius International, Miller Electric, and Air Liquide are focusing on automation, advanced welding technologies, and sustainable materials to improve efficiency, precision, and performance in diverse industrial applications.
The welding equipment, accessories, and consumables market is projected to grow from USD 35.84 billion in…  
                                        
                                     
                                            
                                                    Procolored Announces 2025 Black Friday & Cyber Monday Deals Across DTF and UV Pr …                                                
                                            
                                        
                                            Industry-leading print manufacturer unveils limited-time offers, bundles, and loyalty rewards for U.S. customers.
Shenzhen - Today, Procolored [https://www.procolored.com/], global manufacturer of DTF, UV DTF, and UV printers, announced its 2025 Black Friday and Cyber Monday sale event, featuring deep discounts, bundles, and loyalty rewards across its product lineup. The promotional period spans November 1 to December 7, 2025, with exclusive offers available to U.S. customers through Procolored.com and Amazon.
Black Friday Season…  
                                        
                                     
                                            
                                                    Mobility Indy's Donation Helps Create Lasting Memory for Family Facing Cancer                                                
                                            
                                        
                                            Mobility Indy provided a free scooter rental for a young mother battling cancer, enabling a cherished family outing at the Children's Museum.
INDIANAPOLIS, IN - October 31, 2025 - Mobility Indy [https://mobilityindy.com/], a local provider of mobility solutions, partnered with the nonprofit organization One Day to Remember [https://www.onedaytoremember.org/] to provide a free scooter rental [https://mobilityindy.com/rentals/mobility-scooters/] and personal delivery for a young mother battling metastatic lung cancer, allowing her to enjoy a…  
                                        
                                     
                                            
                                                    Ceramic Matrix Composites Market Future Demand, Revenue Forecast, and Strategic  …                                                
                                            
                                        
                                            The Ceramic Matrix Composites (CMCs) Market is witnessing strong growth, fueled by rising demand from aerospace, defense, and energy industries for lightweight, high-strength, and heat-resistant materials. Key players such as GE Aviation, Rolls-Royce, SGL Carbon, CoorsTek, and Lancer Systems are focusing on material innovation, production efficiency, and strategic collaborations to enhance performance and sustainability in high-temperature applications.
The ceramic matrix composite market is projected to reach USD 20.83 billion by 2030…  
                                        
                                    More Releases for Retinal
                                                    Retinal Disorder Treatment: Core Growth Enabler in the Rising Incidence Of Retin …                                                
                                            
                                        
                                            Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Retinal Disorder Treatment Industry Market Size Be by 2025?
In past years, the retinal disorder treatment market has witnessed significant growth. The market worth which stood at $12.59 billion in 2024, is expected to surge to $13.69 billion in 2025, approximating a compound annual growth rate…  
                                        
                                    
                                                    Retinal Biologics Market Size: Targeted Treatments for AMD, DME & Retinal Diseas …                                                
                                            
                                        
                                            Retinal Biologics Market reached US$ 24.16 Billion in 2024 and is expected to reach US$ 40.46 Billion by 2033, growing at a CAGR of 5.9% during the forecast period 2025-2033.
Retinal Biologics Market Report by DataM Intelligence delivers deep insights and analysis into the latest market trends, growth opportunities, and emerging challenges. Designed to help businesses make smarter, faster decisions, our reports combine both data-driven analysis and expert perspectives. At DataM…  
                                        
                                    
                                                    Key Influencer in the Retinal Disorder Treatment Market 2025: Rising Incidence O …                                                
                                            
                                        
                                            What combination of drivers is leading to accelerated growth in the retinal disorder treatment market?
The escalation in retinal disorder instances is anticipated to fuel the expansion of the retinal disorder treatment market. Retinal diseases are health issues that influence the retina, the light-sensitive tissue at the rear of the eye, potentially leading to vision loss or significant visual impairment. Treatments for retinal disorders, such as laser therapy, vitrectomy, and retinal…  
                                        
                                    
                                                    Retinal Biologics Market Report 2024 - Retinal Biologics Market Insights, Size A …                                                
                                            
                                        
                                            "The Business Research Company recently released a comprehensive report on the Global Retinal Biologics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…  
                                        
                                    
                                                    Retinal Implants Sales Market Analysis By Top Players - Second Sight Medical Pro …                                                
                                            
                                        
                                            Worldwide Market Reports has announced the addition of the “Global Retinal Implants Market Size Status and Forecast 2022”, The report classifies the global Retinal Implants Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.
Global Retinal Implants market competition by top manufacturers/players, with Retinal Implants sales volume, Price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player;…  
                                        
                                    
                                                    Retinal Implants Sales Market Analysis By Top Players - Second Sight Medical Pro …                                                
                                            
                                        
                                            Worldwide Market Reports has announced the addition of the “Global Retinal Implants Market Size Status and Forecast 2022”, The report classifies the global Retinal Implants Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.
Global Retinal Implants market competition by top manufacturers/players, with Retinal Implants sales volume, Price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player;…  
                                        
                                    